DIMED (PNVL3) Main Indicators
Basic Data - PNVL3
Company | DIMED |
Corporate Name | DIMED S.A. DISTRIBUIDORA DE MEDICAMENTOS |
Registration Status | ATIVO |
Issuer Status | FASE OPERACIONAL |
Listing Segment | Novo Mercado |
Activity | Comercio atacadista e varejista de medicamentos e produtos de perfumaria e toucador |
Share | PNVL3 |
Quote Date | 12/06/2024 |
Share Type | ON |
Last Closing | R$ 9.45 |
Quotation Factor | 1 Share |
Financial Volume | R$ 2.48 M |
Last Statement | ITR - 09/30/2024 |
Sector | Saúde |
Subsector | Comércio e Distribuição |
Segment | Medicamentos e Outros Produtos |
Participation Indexes | IBRA, ICON, IGC, IGCT, IGNM, ITAG, SMLL |
Updated 12/07/2024 |
Relative Prices - PNVL3
Price/Earnings | 13.72 |
Price/SBV | 1.19 |
Price/Net Sales | 0.29 |
Price/CFO | 5.18 |
Price/FCF | 9.02 |
Price/Total Assets | 0.44 |
Price/EBIT | 7.78 |
Price/Working Capital | 1.98 |
Price/NCAV | -1.08 |
EV/EBIT | 13.97 |
EV/EBITDA | 6.56 |
EV/Net Sales | 0.53 |
EV/CFO | 9.30 |
EV/FCF | 16.20 |
EV/Total Assets | 0.79 |
Company Market Cap | R$ 1.42 B |
Enterprise Value | R$ 2.55 B |
Current Financial Statement Date | 09/30/2024 |
Current Share Price | R$ 9.45 |
Share Price Date | 12/06/2024 |
Dividend Yield | 3.79% |
Updated 12/07/2024 |
Income Statement - PNVL3
Net Revenue | R$ 4.82 B |
Gross Result | R$ 1.52 B |
EBIT | R$ 182.67 M |
Depreciation and Amortization | - R$ 206.59 M |
EBITDA | R$ 389.26 M |
Net Profit | R$ 103.55 M |
Net Profit/Share | R$ 0.69 |
Updated 11/13/2024 |
Net Revenue | R$ 1.24 B |
Gross Result | R$ 390.04 M |
EBIT | R$ 63.17 M |
Depreciation and Amortization | - R$ 52.30 M |
EBITDA | R$ 115.46 M |
Net Profit | R$ 35.86 M |
Profit/Share | R$ 0.24 |
Updated 11/13/2024 |
Price and Volume Behavior - PNVL3
Lowest Price 52 weeks | R$ 9.28 |
Highest Price 52 weeks | R$ 13.06 |
Variation 2024 | -26.50% |
Variation 1 year | -20.58% |
Variation 2 years(total) | -4.26% |
Variation 2 years(yearly) | -2.15% |
Variation 3 years(total) | -21.01% |
Variation 3 years(yearly) | -7.56% |
Variation 4 years(total) | -54.41% |
Variation 4 years(yearly) | -17.79% |
Variation 5 years(total) | -43.88% |
Variation 5 years(yearly) | -10.88% |
Average Daily Volume (3 months) | R$ 3.28 M |
Updated 12/07/2024 |
Returns and Margins - PNVL3
Return on Initial Tangible Capital | 5.67% |
Return on Initial Invested Capital | 5.48% |
Pre-Tax Return on Initial Tangible Capital | 8.59% |
Pre-Tax Return on Initial Invested Capital | 8.31% |
Return on Initial Shareholder´s Equity | 9.09% |
Return on Initial Asset | 3.52% |
Gross Margin | 31.64% |
Net Margin | 2.15% |
EBIT Margin | 3.79% |
EBITDA Margin | 8.08% |
Initial Asset Turnover | 1.64 |
Financial Leverage | 2.70 |
Liabilities/Net Worth | 1.70 |
Net Debt/EBITDA | 2.91 |
Updated 11/13/2024 |
Balance Sheet - PNVL3
Cash and Cash Equivalents | R$ 12.18 M |
Total Assets | R$ 3.23 B |
Short-Term Debt | R$ 325.88 M |
Long-Term Debt | R$ 817.96 M |
Gross Debt | R$ 1.14 B |
Net Debt | R$ 1.13 B |
Shareholder´s Equity | R$ 1.20 B |
Share Book Value | R$ 7.95 |
Common Shares | 150,377,841 |
Preferred Shares | 0 |
Total | 150,377,841 |
Common Shares in Treasury | 1,019,944 |
Preferred Shares in Treasury | 0 |
Total in Treasury | 1,019,944 |
Common Shares (Except Treasury) | 149,357,897 |
Preferred Shares (Except Treasury) | 0 |
Total (Except Treasury) | 149,357,897 |
Updated 11/13/2024 |
Cash Flow - PNVL3
Operating Cash Flow | R$ 274.49 M |
Cash Flow from Investments | - R$ 60.93 M |
Financing Cash Flow | - R$ 216.97 M |
Increase (Reduction) in Cash and Equivalents | - R$ 3.40 M |
Updated 11/13/2024 |
Operating Cash Flow | R$ 30.83 M |
Cash Flow from Investments | R$ 18.04 M |
Financing Cash Flow | - R$ 53.39 M |
Increase (Reduction) in Cash and Equivalents | - R$ 4.53 M |
Updated 11/13/2024 |
Experimental - PNVL3
CAPEX 3 months | - R$ 45.09 M |
Free Cash Flow 3 months | - R$ 14.26 M |
CAPEX 12 months | - R$ 116.94 M |
Free Cash Flow 12 months | R$ 157.55 M |
Updated 11/13/2024 |